Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: Preliminary results

International Journal of Hyperthermia

Volumn 25, Issue 2, 2009, Pages 160-167

  Ohguri, Takayuki ^a   Imada, Hajime ^a   Narisada, Hiroyuki ^b   Yahara, Katsuya ^a   Morioka, Tomoaki ^a   Nakano, Keita ^a   Miyaguni, Yasuhiro ^a   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Tobata Hospital   (Japan)

Author keywords

Chemotherapy; Hyperbaric oxygen; Hyperthermia; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; GLUCOSE; GRANISETRON; PACLITAXEL; RANITIDINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; BURN; CARDIOTOXICITY; CLINICAL ARTICLE; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; FATIGUE; FEMALE; HEARING IMPAIRMENT; HUMAN; HYPERBARIC OXYGEN; HYPERSENSITIVITY REACTION; HYPERTHERMIC THERAPY; LEUKOPENIA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; PNEUMONIA; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SUBCUTANEOUS FAT DISORDER; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; DISEASE FREE SURVIVAL; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERBARIC OXYGENATION; HYPERTHERMIA, INDUCED; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67649667150     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730802610357     Document Type: Article

References (42)

1. Non-small Cell Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: Ameta-analysis using updated data on individual patients from 52 randomized trials. Br Med J 1995;311:899-909.
2. Bunn PA, Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: Areview of the literature and future directions. Clin Cancer Res 1998;5:1087-1100.
3. Jones EL, Samulski TV, Vujaskovic Z, Leonard RP, Dewhirst MW. Hyperthermia. In: Perez CA, Brady LW, Halperin WC, and Schmidt-Ullrich RK, editors. Principles and Practice of Radiation Oncology, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2003. pp 699-735.
4. Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008;24:251-261.
5. Xu MJ, Alberts DS. Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemother Pharmacol 1988;21:191-196.
6. Herman TS, Teicher BA, Chan V, Collins LS, Abrams MJ. Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 1989;16:443-449.
7. Othman T, Goto S, Lee JB, Taimura A, Matsumoto T, Kosaka M. Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 2001;62:208-212.
8. Cividalli A, Cruciani G, Livdi E, Pasqualetti P, Tirindelli Danesi D. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. Int J Radiat Oncol Biol Phys 1999;44:407-412.
9. Rietbroek RC, Katschinski DM, Reijers MH, Robins HI, Geerdink A, Tutsch K, d'Oleire F, Haveman J. Lack of thermal enhancement for taxanes in vitro. Int J Hyperthermia 1997;13:525-533.
10. Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003;10:463-468.
11. Zoul Z, Filip S, Melichar B, Dvorák J, Odrázka K, Petera J. Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy - A pilot experience. Onkologie 2004;27:385-388.
12. Kodama K, Doi O, Higashiyama M, Yokouchi H, Tatsuta M. Long-term results of postoperative intrathoracic chemothermotherapy for lung cancer with pleural dissemination. Cancer 1993;72:426-431.
13. Alagoz T, Buller RE, Anderson B, Terrell KL, Squatrito RC, Niemann TH, Tatman DJ, Jebson P. Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer 1995;75:2313-2322.
14. Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: Apotential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 2005;11:279-289.
15. Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Nakajima N. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: Evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 2001;47:11-14.
16. Huang JL, Shao ZA, Yang AQ, Shi JM, Li FC, Guo ZW. Hyperbaric oxygen and antineoplastic drugs in the treatment of intermediate and advanced hepatic cancer. J Hyperbaric Med 1991;6:155-157.
17. Kawamura N, Matsunaga J, Tazaki H. Experience with massive anti-cancer chemotherapy under hyperbaric oxygen pressure in terminal urologic malignancy. Tokai J Exp Clin Med 1978;3:183-192.
18. Calvert AH, Newell DR, Gumbrell LA. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;17:1748-1756.
19. Schem BC, Dahl O. Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma. J Neurooncol 1991;10:247-252.
20. Song CW, Rhee JG, Lee CK, Levitt SH. Capacitive heating of phantom and human tumors with an 8MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 1986;12:365-372.
21. Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M. Radiofrequency capacitive hyperthermia for deepseated tumors. I. Studies on thermometry. Cancer 1987;60:121-127. (Pubitemid 17083563)
22. Hamazoe R, Maeta M, Murakami A, Yamashiro H, Kaibara N. Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep-seated tumors in the peritoneal cavity. J Surg Oncol 1991;48:176-179.
23. Imada H. Development of new heating technique. In: Matsuda T, Sugawara T, Abe M, and Tanaka Y, editors. Hyperthermia No Rinsho (in Japanese). Tokyo: Iryokagaku; 1999. pp 394-402.
24. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
25. Feldmann HJ, Seegenschmiedt MH, Molls M. Hyperthermia - Its actual role in radiation oncology. Part III: Clinical rationale and results in deep seated tumors. Strahlenther Onkol 1995;171:251-264.
26. van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. The Kadota Fund International Forum 2004 - Clinical group consensus. Int J Hyperthermia 2008;24:111-122.
27. Issels RD, Abdel-Rahman S, Wendtner C, Falk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study. Eur J Cancer 2001;37:1599-1608. (Pubitemid 32778604)
28. de Wit R, van der Zee J, van der Burg ME, Kruit WH, Logmans A, van Rhoon GC, Verweij J. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 1999;80:1387-1391.
29. Westermann AM, Grosen EA, Katschinski DM, Jäger D, Rietbroek R, Schink JC, Tiggelaar CL, Jäger E, Zum Vörde sive Vörding P, Neuman A, et al. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer 2001;37:1111-1117.
30. Belani CP, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM. Multicenter, randomized trail for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol 2003;21:2933-2939.
31. Loesch D, Robert N, Asmar L, Gregurich MA, O'Rourke M, Dakhil S, Cox E. Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer. J Clin Oncol 2002;20:3857-3864.
32. Havrilesky LJ, Alvarez AA, Sayer RA, Lancaster JM, Soper JT, Berchuck A, Clarke-Pearson DL, Rodriguez GC, Carney ME. Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer. Gynecol Oncol 2003;88:51-57.
33. Kallab AM, Nalamolu Y, Dainer PM, Jillella AP. A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer. Med Oncol 2005;22:145-151.
34. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (-65 years of age): Aphase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003;26:441-447.
35. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-98.
36. Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: ASouthwest Oncology Group Trial. J Clin Oncol 2001;19:3210-3218.
37. Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: Acooperative multinational trial. Ann Oncol 2002;13:1539-1549. (Pubitemid 35331451)
38. Itaya T, Yamaoto N, Ando M, Ebisawa M, Nakamura Y, Murakami H, Asai G, Endo M, Takahashi T. Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer. Cancer Sci 2007;98:226-230.
39. Kalns J, Krock L, Piepmeier Jr E. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 1998;18:363-367.
40. Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001;155:515-528.
41. Hiraoka M, Masunaga S, Nishimura Y, Nagata Y, Jo S, Akuta K, Li YP, Takahashi M, Abe M. Regional hyperthermia combined with radiotherapy in the treatment of lung cancers. Int J Radiat Oncol Biol Phys 1992;22:1009-1014.
42. Karasawa K, Muta N, Nakagawa K, Hasezawa K, Terahara A, Onogi Y, Sakata K, Aoki Y, Sasaki Y, Akanuma A. Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1994;30:1171-1177.